title: PAP modulations in Daudi cells and Molt-3 cells treated with etoposide are mutually associated with morphological evidence of apoptosis.
abstract: Daudi (B-cell line) and Molt-3 (T-cell line) cells provide a model for the study of apoptosis, the induction of which is often accompanied by concominant modulations of proteins involved in mRNA maturation. One of these proteins is poly(A) polymerase (PAP), which is responsible for mRNA cleavage and polyadenylation. A number of recent reports also suggest involvement of mRNA maturation and stability in the induction of specific pathways of cell apoptosis. In this study we identified PAP activity levels and isoform modulations in two different cell lines (Daudi and Molt-3) and related them to DNA fragmentation (a hallmark of apoptosis) and cell cycle phase specificity in terms of the temporal sequence of events and the time that elapsed between administration of the apoptosis inducer (the widely used anticancer drug etoposide) and the observed effects. Treatment of both cell lines with 20 microg/mL etoposide induced apoptosis after four hours in Molt-3 cells and only after 24 hours in Daudi cells, as revealed by two independent methods. In Daudi cells the PAP activity levels and isoforms were downregulated prior to deltapsim reduction, DNA fragmentation and the morphological changes of the nucleus, whereas in Molt-3 cells no PAP activity and isoform modulations were observed prior to the early hallmarks of apoptosis.
authors.affiliation: Institute of Biology, NCSR Demokritos, Aghia Paraskevi Attikis, Athens--Greece.
authors.forename: E
authors.initials: E
authors.lastname: Thomadaki
authors.forename: M
authors.initials: M
authors.lastname: Havredaki
authors.forename: C M
authors.initials: CM
authors.lastname: Tsiapalis
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D053178:Caspase 6; D020169:Caspases / Q000378:metabolism; D002453:Cell Cycle; D045744:Cell Line, Tumor; D002463:Cell Membrane Permeability; D004273:DNA, Neoplasm / Q000378:metabolism; D005047:Etoposide / Q000494:pharmacology*; D006801:Humans; D007425:Intracellular Membranes / Q000187:drug effects; D008564:Membrane Potentials / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects / Q000502:physiology; D011062:Polynucleotide Adenylyltransferase / Q000378:metabolism*; D013997:Time Factors
chemical_list: D004273:DNA, Neoplasm; D005047:Etoposide; D011062:Polynucleotide Adenylyltransferase; C505514:CASP6 protein, human; D053178:Caspase 6; D020169:Caspases